Rocket Pharmaceuticals Inc Q2 2021 Earnings Call Transcript - Thomson StreetEvents

Rocket Pharmaceuticals Inc Q2 2021 Earnings Call Transcript

Rocket Pharmaceuticals Inc Q2 2021 Earnings Call Transcript - Thomson StreetEvents
Rocket Pharmaceuticals Inc Q2 2021 Earnings Call Transcript
Published Aug 09, 2021
13 pages (7596 words) — Published Aug 09, 2021
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of RCKT.OQ earnings conference call or presentation 9-Aug-21 8:30pm GMT

  
Brief Excerpt:

...Operator Welcome to the Rocket Pharmaceuticals Inc. Investor Conference Call. My name is Vanessa, and I will be your operator for today's call. (Operator Instructions). I will now turn the call over to your host, Mayur Kasetty, Director of Business Development and Operations. Mayur Kasetty Thank you, Vanessa. Good afternoon, everyone. This is Mayur Kasetty, Director of Business Development and Operations and Investor Relations Lead at Rocket Pharmaceuticals. Thank you for joining us. The purpose of this call is to share and discuss key updates on our clinical programs. Before we begin, I would like to briefly discuss the use of forward-looking statements on this conference call. Statements we make on this call may include statements which are not historical facts and are considered forward-looking within the meaning of the securities laws and which are usually identified by the use of words such as anticipates, believes, estimates, expects, intends, may, plans, projects, seeks, should,...

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Rocket Pharmaceuticals Inc
Ticker
RCKT.OQ
Time
8:30pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Gil Joseph Blum - Needham & Company, LLC, Research Division - Analyst : Just about the death that happened on the IMO study, is there really any significant differences between the conditioning regimen seeing in transplant in these patients versus the gene therapy? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. AUGUST 09, 2021 / 8:30PM, RCKT.OQ - Q2 2021 Rocket Pharmaceuticals Inc Earnings Call

Question: Gil Joseph Blum - Needham & Company, LLC, Research Division - Analyst : No, just versus the hematopoietic stem cell transplant, which is sometimes viewed as the standard of care.

Question: Gil Joseph Blum - Needham & Company, LLC, Research Division - Analyst : Yes.

Table Of Contents

Rocket Pharmaceuticals Inc at Needham Healthcare Conference Transcript – 2022-04-11 – US$ 54.00 – Edited Transcript of RCKT.OQ presentation 11-Apr-22 2:15pm GMT

Rocket Pharmaceuticals Inc at Guggenheim Genomic Medicines and Rare Disease Day (Virtual) Transcript – 2022-04-01 – US$ 54.00 – Edited Transcript of RCKT.OQ presentation 1-Apr-22 12:00pm GMT

Rocket Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript – 2022-01-10 – US$ 54.00 – Edited Transcript of RCKT.OQ presentation 10-Jan-22 6:30pm GMT

Rocket Pharmaceuticals Inc to Host In-Person Investor and Analyst Event Transcript – 2021-12-14 – US$ 54.00 – Edited Transcript of RCKT.OQ corporate analyst meeting</ 14-Dec-21 12:30pm GMT

Rocket Pharmaceuticals Inc Danon Update Call Transcript – 2021-11-15 – US$ 54.00 – Edited Transcript of RCKT.OQ conference call or presentation 15-Nov-21 1:30pm GMT

Rocket Pharmaceuticals Inc to Discuss Danon Program Call Transcript – 2021-05-10 – US$ 54.00 – Edited Transcript of RCKT.OQ conference call or presentation 10-May-21 8:30pm GMT

Rocket Pharmaceuticals Inc at JPMorgan Healthcare Conference (Virtual) Transcript – 2021-01-11 – US$ 54.00 – Edited Transcript of RCKT.OQ presentation 11-Jan-21 7:50pm GMT

Rocket Pharmaceuticals, Inc. - Special Call Transcript – 2020-12-08 – US$ 54.00 – Edited Transcript of RCKT.OQ conference call or presentation 8-Dec-20 9:15pm GMT

Rocket Pharmaceuticals, Inc. - Special Call Transcript – 2020-12-07 – US$ 54.00 – Edited Transcript of RCKT.OQ conference call or presentation 7-Dec-20 11:00pm GMT

Rocket Pharmaceuticals Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2020-09-17 – US$ 54.00 – Edited Transcript of RCKT.OQ presentation 17-Sep-20 6:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Rocket Pharmaceuticals Inc Q2 2021 Earnings Call Transcript" Aug 09, 2021. Alacra Store. May 16, 2024. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2021-Rocket-Pharmaceuticals-Inc-Earnings-Call-T14946485>
  
APA:
Thomson StreetEvents. (2021). Rocket Pharmaceuticals Inc Q2 2021 Earnings Call Transcript Aug 09, 2021. New York, NY: Alacra Store. Retrieved May 16, 2024 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q2-2021-Rocket-Pharmaceuticals-Inc-Earnings-Call-T14946485>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.